Opioid‐free vs. opioid‐inclusive anaesthesia in laparoscopic cholecystectomy: a multicentre randomised controlled trial*
BACKGROUND: Laparoscopic cholecystectomy is the most common abdominal operation worldwide, yet whether opioid-free anaesthesia improves the overall analgesic benefit remains uncertain. METHODS: In this multicentre randomised controlled trial, adults undergoing elective laparoscopic cholecystectomy were randomised 1:1 to receive opioid-free anaesthesia (dexmedetomidine, esketamine and sevoflurane) or opioid-inclusive anaesthesia (sufentanil and sevoflurane). Patients received prophylactic anti-emetics and multimodal analgesia with flurbiprofen axetil and ropivacaine wound infiltration. The primary outcome was the overall benefit of analgesia score (0-28, lower scores indicate greater benefit) at 24 h postoperatively; a 3-point difference was considered clinically relevant. Secondary outcomes included pain on movement at 24 h and chronic postsurgical pain at 90 days. RESULTS: Between March and September 2025, 315 patients completed this trial (158 opioid-free, 157 opioid-inclusive). The mean (SD) 24-h overall benefit of analgesia score was 2.2 (2.4) after opioid-free anaesthesia vs 3.4 (3.1) after opioid-inclusive anaesthesia (adjusted mean difference -1.3; 95%CI -1.8 to -0.8, p < 0.001), without reaching the threshold for clinical importance. Incidence of pain on movement (adjusted mean difference -0.2; 95%CI -0.4-0) and chronic postsurgical pain (16.1% vs 15.5%; adjusted relative risk 1.03; 95%CI 0.55-1.91) did not differ between groups. Opioid-free anaesthesia was associated with reduced intra-operative hypotension (19.6% vs 35.7%; relative risk 0.55; 95%CI 0.37-0.80) and lower incidence of postoperative nausea and vomiting (23.4% vs 33.8%; relative risk 0.69; 95%CI 0.48-0.98). DISCUSSION: Opioid-free anaesthesia did not achieve a clinically meaningful improvement in overall benefit of analgesia. These findings do not support its routine adoption in laparoscopic cholecystectomy. However, the observed reductions in intra-operative hypotension and postoperative nausea and vomiting suggest that this regimen may warrant consideration in selected patients, pending validation in future trials.
Authors
- Fuhai Ji (ORCID: https://orcid.org/0000-0001-6649-665X)
- Ke Peng (ORCID: https://orcid.org/0000-0003-2879-1759)
- Wenya Guo
- Jiayu Jin
- Yun Li
- Liu Han
- Dan Wang
- Jing‐hui Hu
Institutions
- Anhui Medical University (CN)
- Soochow University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Soochow University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Anaesthesia
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1111/anae.70462
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00